Clinical Trials Directory

Trials / Completed

CompletedNCT03388099

Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response

Status
Completed
Phase
Study type
Observational
Enrollment
296 (actual)
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Aim of study: To compare the relationship between serum AMH and ovarian response for IVF with the GnRH antagonist protocol in patients who are carriers of FSH and/or LH receptor polymorphisms with those that are not.

Detailed description

Serum AMH has shown to have a high predictive capability of the ovarian response to stimulation for IVF. On the other hand, patients who are carriers of polymorphisms in the FSH and LH receptors, have shown to need higher doses of gonadotrophins for ovarian stimulation. The proportion of carriers has been described to be around 20% of the population. Nevertheless, the determination of these polymorphisms is not performed in routine practice. It is unknown if their presence affects to the relationship between serum AMH levels and ovarian response. This is a prospective, single center, non-interventional, cohorts study.

Conditions

Timeline

Start date
2018-01-11
Primary completion
2019-12-18
Completion
2019-12-18
First posted
2018-01-02
Last updated
2019-12-20

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03388099. Inclusion in this directory is not an endorsement.

Impact of Gonadotrophin REceptor Polimorphisms on the Relationship Between Serum AMH and Ovarian Response (NCT03388099) · Clinical Trials Directory